We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Open Drawer MenuClose Drawer Menu
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
CorrigendumFree Access

Corrigendum

    Published Online:4 May 2012https://doi.org/10.2217/pme.12.26

    In the article: D’Alessandro LC, Mital S. Pediatric transplantation: opportunities for pharmacogenomics and genomics. Personalized Medicine 10(4), 397–404 (2013) (www.futuremedicine.com/doi/full/10.2217/PME.13.26), on page 400 the following sentence incorrectly appeared as:

    Adult studies have identified two SNPs in the SLCO1B1 gene to be significantly associated with statin myopathy: a noncoding SNP (-11187G>A rs4363657) in intron 11 and a nonsynonymous SNP (521T>C Val174Ala rs4149056) in exon 6, with highest risk (18%) in those with the 521CC genotype [39].

    The correct sentence is shown below:

    Adult studies have identified two SNPs in the SLCO1B1 gene to be significantly associated with statin myopathy: a noncoding SNP (1498-1331T>C rs4363657) in intron 11 and a nonsynonymous SNP (521T>C Val174Ala rs4149056) in exon 6, with highest risk (18%) in those with the 521CC genotype [39].

    The authors would like to sincerely apologize for any confusion or inconvenience caused.